AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Date	Type	Amount	Amount (Split Adj)	Record Date	Pay Date
Feb 22, 2024	Cash	£1.56	£1.56	Feb 23, 2024	Mar 25, 2024
Aug 10, 2023	Cash	£0.718	£0.718	Aug 11, 2023	Sep 11, 2023
Feb 23, 2023	Cash	£1.628	£1.628	Feb 24, 2023	Mar 27, 2023
Aug 11, 2022	Cash	£0.764	£0.764	Aug 12, 2022	Sep 12, 2022
Feb 24, 2022	Cash	£1.453	£1.453	Feb 25, 2022	Mar 28, 2022
Aug 12, 2021	Cash	£0.648	£0.648	Aug 13, 2021	Sep 13, 2021
Feb 25, 2021	Cash	£1.374	£1.374	Feb 26, 2021	Mar 29, 2021
Aug 13, 2020	Cash	£0.696	£0.696	Aug 14, 2020	Sep 14, 2020
Feb 27, 2020	Cash	£1.464	£1.464	Feb 28, 2020	Mar 30, 2020
Aug 08, 2019	Cash	£0.719	£0.719	Aug 09, 2019	Sep 09, 2019
Feb 28, 2019	Cash	£1.468	£1.468	Mar 01, 2019	Mar 27, 2019
Aug 09, 2018	Cash	£0.684	£0.684	Aug 10, 2018	Sep 10, 2018
Feb 15, 2018	Cash	£1.336	£1.336	Feb 16, 2018	Mar 19, 2018
Aug 10, 2017	Cash	£0.689	£0.689	Aug 11, 2017	Sep 11, 2017
Feb 16, 2017	Cash	£1.502	£1.502	Feb 17, 2017	Mar 20, 2017

AstraZeneca PLC

Dividends